Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mona Maharjan"'
Publikováno v:
BMC Bioinformatics, Vol 21, Iss S9, Pp 1-19 (2020)
Abstract Background Lung cancer is the number one cancer killer in the world with more than 142,670 deaths estimated in the United States alone in the year 2019. Consequently, there is an overreaching need to identify the key biomarkers for lung canc
Externí odkaz:
https://doaj.org/article/1b89c0fddb194574b43f45192c534066
Publikováno v:
Data, Vol 4, Iss 2, p 81 (2019)
Two graph theoretic concepts—clique and bipartite graphs—are explored to identify the network biomarkers for cancer at the gene network level. The rationale is that a group of genes work together by forming a cluster or a clique-like structures t
Externí odkaz:
https://doaj.org/article/bbf5ae2a6540477ebad0954cad612f99
Publikováno v:
BMC Bioinformatics
BMC Bioinformatics, Vol 21, Iss S9, Pp 1-19 (2020)
BMC Bioinformatics, Vol 21, Iss S9, Pp 1-19 (2020)
Background Lung cancer is the number one cancer killer in the world with more than 142,670 deaths estimated in the United States alone in the year 2019. Consequently, there is an overreaching need to identify the key biomarkers for lung cancer. The a
Publikováno v:
BCB
Finding the biomarkers of cancers and the analysis of cancer-driving genes that are involved in these biomarkers are essential for understanding the dynamics of cancer. Gene expression profiling has been widely used for cancer research, and its patte
Publikováno v:
Data
Volume 4
Issue 2
Data, Vol 4, Iss 2, p 81 (2019)
Volume 4
Issue 2
Data, Vol 4, Iss 2, p 81 (2019)
Two graph theoretic concepts&mdash
clique and bipartite graphs&mdash
are explored to identify the network biomarkers for cancer at the gene network level. The rationale is that a group of genes work together by forming a cluster or a clique
clique and bipartite graphs&mdash
are explored to identify the network biomarkers for cancer at the gene network level. The rationale is that a group of genes work together by forming a cluster or a clique
Publikováno v:
Cancer Research. 80:3956-3956
Cancer recurrence after therapy and long periods of remission are frequent in melanoma patients, likely due to the presence of residual disseminated tumor cells (DTCs). DTCs can enter dormancy and become refractory to targeted or conventional therapi